GÜRLER, F. Et Al. 2021. Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment. 11th International Gastrointestinal Cancers Conference , (Ankara, Turkey).

GÜRLER, F., İLHAN GÜLEŞEN, A., & ÇAKMAK ÖKSÜZOĞLU, Ö. B., (2021). Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment . 11th International Gastrointestinal Cancers Conference, Ankara, Turkey

GÜRLER, FATİH, AYŞEGÜL İLHAN GÜLEŞEN, And ÖMÜR BERNA ÇAKMAK ÖKSÜZOĞLU. "Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment," 11th International Gastrointestinal Cancers Conference, Ankara, Turkey, 2021

GÜRLER, FATİH Et Al. "Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment." 11th International Gastrointestinal Cancers Conference , Ankara, Turkey, 2021

GÜRLER, F. İLHAN GÜLEŞEN, A. And ÇAKMAK ÖKSÜZOĞLU, Ö. B. (2021) . "Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment." 11th International Gastrointestinal Cancers Conference , Ankara, Turkey.

@conferencepaper{conferencepaper, author={FATİH GÜRLER Et Al. }, title={Retrospective Comparison of mFOLFIRINOX And Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment}, congress name={11th International Gastrointestinal Cancers Conference}, city={Ankara}, country={Turkey}, year={2021}}